FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Publications
  • Links
  • News
✕

PhD studentship 65% open in Project 5

Project 5 “Myeloid cell function in corneal hem- and lymphangiogenesis” ) in the Research Unit FOR 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye” (Speaker: Univ.-Prof. Dr. med. Claus Cursiefen, FEBO, FARVO and Vice-Speaker: Univ.-Prof. Dr. rer. nat. Thomas Langmann) in the Department of Ophthalmology at the University Hospital of Cologne is now seeking applications for one PhD position for 36 months. Project 5 is led by Dr. nat. med. Dr. med. Deniz Hos, FEBO and Univ.-Prof. Dr. med. Sabine Eming.

The following links provide access to an advertisement with more details about the position, the project and the supervisors:  FOR 2240 P5 PhD Hos englisch and FOR 2240 P5 PhD Hos deutsch.

In the pdfs above you will also see further instructions about how to apply. The position is open until filled.

Related posts

SFB 1607 Launches Website and Celebrates TEO-C New Lab Location


Read more

New SFB 1607 Launched – Building on the Foundations of FOR2240


Read more

Fakultaetspreise 2024

Faculty prize for PD Dr. Schrittenlocher – Awarded for best habilitation in 2022


Read more

News

  • SFB 1607 Launches Website and Celebrates TEO-C New Lab Location
  • New SFB 1607 Launched – Building on the Foundations of FOR2240
  • Faculty prize for PD Dr. Schrittenlocher – Awarded for best habilitation in 2022
  • DOG poster award for Dr. Martina Maaß
  • Young Cologne Eye Researcher Šejla Gegić won Margarete Kramer Prize

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Claudia Bock
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
claudia.bock@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck
      Um unsere Website für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies und insb. der Möglichkeiten, der Verwendung von Cookies zu widersprechen, erhalten Sie in unserer Datenschutzerklärung.